OutPerformDaily

  • Tech Stocks
  • Cannabis Stocks
  • Index Funds
  • International
  • Short
  • Stock Picks

Lost Password?
Where Will IonQ Stock Be in 1 Year?

Where Will IonQ Stock Be in 1 Year?

Dow Jones Futures Rise But Robinhood, Astera Dive; AI Fears Slam These Stocks

Dow Jones Futures Rise But Robinhood, Astera Dive; AI Fears Slam These Stocks

Buoyant stocks pause for breath on signs of softening US consumption

Why Datadog Stock Skyrocketed Today

Astera Labs shares sink 10% as revenue comes up short of some expectations

Ford reports worst quarterly earnings miss in four years, guides for better 2026

OutPerformDaily
  • Tech Stocks
  • Cannabis Stocks
  • Index Funds
  • International
  • Short
  • Stock Picks
OutPerformDaily
  • Tech Stocks
  • Cannabis Stocks
  • Index Funds
  • International
  • Short
  • Stock Picks
3rdPartyFeeds

Biogen beats expectations, hikes outlook as Alzheimer’s drug Leqembi and other new products gain traction

August 1, 2024

Uptake of Biogen's breakthrough Alzheimer's drug, Leqembi, appears to be picking up, with roughly $40 million in sales for the quarter. Read more...

3rdPartyFeeds

Wayfair shares sink as CEO likens home goods slowdown to 2008 financial crisis

August 1, 2024

Online home goods company Wayfair has seen sluggish demand against high interest rates, but repreive could come if the federal reserve cuts rates in September...

3rdPartyFeeds

Dow Jones Futures Rise As Meta Jumps, Nvidia Eyes Key Level; Apple, Amazon On Tap

August 1, 2024

Techs led futures higher early Thursday, as Meta jumped on earnings and Nvidia neared a key level. Apple and Amazon earnings loom. Read More...

3rdPartyFeeds

Jim Cramer on the Possibility of NVIDIA’s (NVDA) China Chip: ‘You Kidding Me’?

August 1, 2024

We recently published a list of Jim Cramer Latest Portfolio: 10 Stocks to Buy and Sell. Since NVIDIA Corp (NASDAQ:NVDA) ranks 1st on the list, it deserves a...

3rdPartyFeeds

Tech Market Sell-Off: 2 Stocks to Buy in 2024 Before It’s Too late

August 1, 2024

Alphabet and Nvidia are worth picking up after their recent slides. Read More...

3rdPartyFeeds

Moderna beats estimates but slashes guidance on low EU sales, competitive U.S. vaccine market

August 1, 2024

Moderna now expects 2024 product revenue to come in between $3 billion and $3.5 billion, down from a previous guidance of $4 billion.  Read more...

3rdPartyFeeds

Missed Out on the AI Stock Wave? Here’s How to Make Sure You Don’t Miss the Next Big Trend.

August 1, 2024

This strategy ensures you capture the next big trend before it dominates the market. Read More...

3rdPartyFeeds

Google and TikTok fined by Russia over banned content

August 1, 2024

Russia has been cracking down on foreign technology companies posting content it labels illegal. Read More...

3rdPartyFeeds

Nvidia CEO Jensen Huang Sold $296 Million of His Company’s Stock in July. Should Investors Be Worried?

August 1, 2024

Huang is selling his Nvidia shares like it's going out of style. But there's more to the story. Read More...

3rdPartyFeeds

Billionaires Are Selling Nvidia Stock and Buying 2 Turbocharged Artificial Intelligence (AI) Stocks Instead

August 1, 2024

These hedge fund billionaires were buying shares of Alphabet and ServiceNow during the first quarter. Read More...

Previous 1 … 798 799 800 801 802 … 8,432 Next
Indices by TradingView
Where Will IonQ Stock Be in 1 Year?

Where Will IonQ Stock Be in 1 Year?

February 11, 2026
Dow Jones Futures Rise But Robinhood, Astera Dive; AI Fears Slam These Stocks

Dow Jones Futures Rise But Robinhood, Astera Dive; AI Fears Slam These Stocks

February 10, 2026

Buoyant stocks pause for breath on signs of softening US consumption

February 10, 2026

Why Datadog Stock Skyrocketed Today

February 10, 2026

Astera Labs shares sink 10% as revenue comes up short of some expectations

February 10, 2026

Categories

  • 3rdPartyFeeds
  • Cannabis Stocks
  • Index Funds
  • International
  • News
  • Short
  • Stock Picks
  • Tech Stocks
  • Uncategorized
Indices by TradingView
While subscribers receive the benefit of Outperformdaily opinions, none of the information contained therein constitutes a recommendation from Outperformdaily that any particular security, portfolio of securities, transaction, option, or investment strategy is suitable for any specific person. You further understand that we will not advise you personally concerning the nature, potential, value or suitability of any particular security, portfolio of securities, transaction, investment strategy or other matter. To the extent any of the information contained in Outperformdaily may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person. Outperformdaily’s past results are not necessarily indicative of future performance. All investments are subject to loss. Our employees and writters typically personally invest in all recommendations, but they are not obligated too. Our employees and writters are prohibited from taking an opposite position from which they write about.